{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:22:24Z","timestamp":1786760544330,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T00:00:00Z","timestamp":1418947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijid.2014.12.033","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T05:02:18Z","timestamp":1419310938000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013"],"prefix":"10.1016","volume":"33","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.12.033_bib0085","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3201\/eid1210.060389","article-title":"Active surveillance for candidemia, Australia","volume":"12","author":"Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2014.12.033_bib0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10096-002-0730-4","article-title":"Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators","volume":"21","author":"B\u00fcchner","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.12.033_bib0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diagmicrobio.2013.08.018","article-title":"Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene","volume":"77","author":"Zhang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.12.033_bib0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jac\/dkn015","article-title":"Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations","volume":"61","author":"Xu","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.12.033_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3343\/alm.2013.33.3.167","article-title":"In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values","volume":"33","author":"Jang","year":"2013","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.ijid.2014.12.033_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diagmicrobio.2010.01.002","article-title":"Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program","volume":"67","author":"Pfaller","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.12.033_bib0115","series-title":"Manual of clinical microbiology","first-page":"1184","article-title":"Candida, Cryptococcus, and other yeasts of medical importance","author":"Warren","year":"1999"},{"key":"10.1016\/j.ijid.2014.12.033_bib0120","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard\u2014third edition. CLSI document M27-A3. Wayne, PA: CLSI; 2008."},{"key":"10.1016\/j.ijid.2014.12.033_bib0125","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.12.033_bib0130","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Fourth informational supplement. CLSI document M27-S4. Wayne, PA: CLSI; 2012."},{"key":"10.1016\/j.ijid.2014.12.033_bib0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.diagmicrobio.2013.03.003","article-title":"TSARY Hospitals. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010","volume":"76","author":"Yang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.12.033_bib0140","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1128\/JCM.41.12.5623-5632.2003","article-title":"Comparison of the susceptibilities of Candida spp to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion","volume":"41","author":"Hazen","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.12.033_bib0145","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/j.1439-0507.2011.02165.x","article-title":"Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study","volume":"55","author":"Schmalreck","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2014.12.033_bib0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkf060","article-title":"Antifungal susceptibilities of Candida spp isolated from blood in Spain and Argentina, 1996\u20131999","volume":"49","author":"Cuenca-Estrella","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.12.033_bib0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13693780802291445","article-title":"The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study","volume":"47","author":"Kim","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2014.12.033_bib0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/339946","article-title":"Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214017512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214017512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:57:40Z","timestamp":1537991860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214017512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":16,"alternative-id":["S1201971214017512"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.12.033","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}